1. Berguli, L., Gregoretti, M. G. and Caligaris-Cappio, F., Cyclosporin A in the treatment of B-chronic lymphocytic leukemia (B-CLL).Leukemia, 8, 1245–1246 (1994).
2. Blasberg, R. G. and Groothuis, D. R., Chemotherapy of brain tumors: physiological and pharmacokinetic considerations.Semin. Oncol., 13, 70–82 (1986).
3. Botling, J., Liminga, G., Larsson, R., Nygren. P. and Nilsson, K., Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein.Int. J. Cancer., 58, 269–274 (1994).
4. Carmichael, J., deGraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchel, J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay; assessment of radiosensitivity.Cancer. Res., 47, 936–942 (1987).
5. Chang, C. H., Horton, J., Schoenfeld, D. and Salazer, O., Comparison of postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas.Cancer, 52, 997–1007 (1983).